Bausch Health Companies | VRX - Umlaufvermögen

Aktienkurs
6.85
Täglich Wechseln
-0.18 -2.49%
Monatlich
-18.22%
Jährlich
-31.55%
Q1 Prognose
6.73




Umlaufvermögen Veränderung Datum
Amgen USD 29.06B 1.17B 2025-12
ANI Pharmaceuticals USD 753.12M 54.72M 2025-12
Aurora Cannabis CAD 445.84M 22M 2025-12
Bausch Health Companies USD 6.16B 92M 2025-12
Biogen USD 8.97B 37.5M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Canopy Growth CAD 524.67M 78.85M 2025-12
Corcept Therapeutics USD 485.46M 55.67M 2025-12
Danaher USD 12.76B 3.15B 2025-12
Drreddys Laboratories INR 3.31B 164.26M 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Novo Nordisk DKK 172.45B 9.43B 2025-12
Pacira USD 547.97M 14.78M 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Phibro Animal Health USD 862.18M 26.39M 2025-12
Prestige Brands USD 433.43M 63.98M 2025-12
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12
Zoetis USD 6.77B 185M 2025-12